Fractionation and characterization of a conjugate between a polymeric drug-carrier and the antitumor drug camptothecin

Bioconjugate Chemistry

Volumn 13, Issue 6, 2002, Pages 1253-1258

  Mendichi, R ^a   Rizzo, V ^b   Gigli, M ^b   Giacometti Schieroni, A ^a  

^a CNR   (Italy)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; BROMINE COMPOUNDS; LIGHT SCATTERING; LITHIUM COMPOUNDS;

ANTITUMOR DRUGS; CAMPTOTHECINS; LINE DETECTORS; MOLAR MASS DISTRIBUTION; MULTI-ANGLE LIGHT SCATTERINGS; MULTI-DETECTORS; POLY(N-(2-HYDROXYPROPYL)METHACRYLAMIDE); POLYMERIC DRUG CARRIERS; SYNTHESISED; UNIVERSAL CALIBRATION;

CALIBRATION;

EID: 0036861412     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc025522d     Document Type: Article

References (23)

1. Gebelein, C. G. (1987) Advances in Biomedical Polymers, p 405, Plenum Press, New York.
2. Konno, T., and Maeda, H. (1987) Neoplasma of the Liver (Okada, K., and Ishak, K. G., Eds.) pp 343-352, Springer-Verlag, New York.
3. Duncan, R. (1992) Drug-polymer conjugates: Potential for improved chemotherapy. Anti-Cancer Drugs 3, 175-210.
4. Dumitriu, S., and Dumitriu, M. (1994) Polymeric Drug Carriers in Polymeric Biomaterials (Dumitriu, S., Ed.) Marcel Dekker Inc., New York.
5. Duncan, R., Dimitrijevic, S., and Evagorou, E. G. (1996) The role of polymer conjugates in the diagnosis and treatment of cancer. Pharma Sci. 6, 237-263.
6. Domb, A.J. (1994) Polymeric Site-Specific Pharmacotherapy, John Wiley & Sons, New York.
7. Takakura, Y., Mahato, R. I., Vishikawa, M., and Hashida, M. (1996) Control of pharmacokinetic profiles of drug-macromolecule conjugates. Adv. Drug Delivery Rev. 19, 377-399.
8. Ottembrite, R. M. (1998) Frontiers in Biomedical Polymer Applications (Ottembrite, R. M., Ed.) Technomic Publishing Co., Lancaster, PA.
9. Mendichi, R., Rizzo, V., Gigli, M., and Schieroni, A. G. (1996) Molecular characterization of polymeric antitumor drug carrier by SEC and universal calibration. J. Liq. Chrom., & Relat. Techn. 19, 1591-1605.
10. Mendichi, R., Rizzo, V., Gigli, M., Razzano, G., Angelucci, F., and Schieroni, A. G. (1998) Molar mass distribution of a polymer-drug conjugate containing the antitumor drug paclitaxel by size exclusion chromatography and universal calibration. J. Liq. Chromatogr. Relat. Teehnol. 21, 1295-1309.
11. Mendichi, R., Rizzo, V., Gigli, M., and Schieroni, A. G. (1998) Dilute solution properties of a polymer antitumor drug carrier by size exclusion chromatography, viscometry, and light scattering. J. Appl. Polym. Sci. 70, 329-338.
12. Vasey, P. A., Kaye, S. B., Morrison, R., Twelves, C., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., Burtles, S., Fraier, D., Frigerio, E., and Cassidy, J. (1999) Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: First member of a new class of chemotherapeutic agents - Drug-polymer conjugates. Clin. Cancer Res. 5, 83-94.
13. Terwogt, J. M. M., Huinink, W. W. t. B., Schellens, J. H. M., Schot, M., Mandjes, I. A. M., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., and Beijnen, J. H. (2001) Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel. Anti-Cancer Drugs 12, 315-323.
14. Caiolfa, V. R., Zamai, M., Fiorino, A., Frigerio, E., Pellizzoni, C., D'Argy, R., Ghiglieri, A., Castelli, M. G., Farao, M., Pesenti, E., Gigli, M., Angelucci, F., and Suarato, A. (2000) Polymer-bound camptothecin: Initial biodistribution and antitumour activity. J. Controlled Release 65, 105-119.
15. Angelucci, F., Orzi, F., Fachin, G., Caiolfa, V., Zamai, M., and Suarato, A. Preparation of polymeric derivatives of camptothecins having antitumor activity. PCT Int. Appl. WO 9917804.
16. Seymour, L. W., Duncan, R., Strohalm, J., and Kopacek, J. (1987) Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J. Biomed. Mater. Res. 21, 1341-1358.
17. Matthews, S. E., Pouton, C. W., and Threadgill, M. D. (1996) Macromolecular systems for chemotherapy and magnetic resonance imaging. Adv. Drug Delivery Rev. 18, 219-267.
18. Krinick, N. L., and Kopecek, J. (1991) Soluble polymers as targetable drug carriers. Handb. Exp. Pharmacol. 100, 105.
19. Kataoka, K. (1997) Targetable polymeric drugs. Controlled Drug Delivery: Challenges and Strategies (Park, K., Ed.) p 49, ACS, Washington, DC.
20. Fraier, D., Frigerio, E., Brianceschi, G., Casati, M., Benecchi, A., and James, C. (2000) Determination of MAG-camptothecin, a new polymer-bound camptothecin derivative, and free camptothecin in dog plasma by HPLC with fluorimetric detection. J. Pharm. Biomed. Anal. 22, 505-514.
21. Mendichi, R., and Schieroni, A. G. (1999) Hyphenated and multidimensional techniques. Use of the single-capillary viscometer detector, on-line to a size exclusion chromatography system with a new pulse-free pump. ACS Symp. Ser. 731, 66-83.
22. Wyatt, P. J. (1993) Light scattering and absolute characterization of macromolecules. Anal. Chim. Acta 272, 1-40.
23. Grubisic, Z., Rempp, P., and Benoit, H. (1967) A universal calibration for gel permeation chromatography. J. Polym. Sci., Part B 5, 753-759.